Clinical • Late-breaking abstract • PD(L)-1 Biomarker • IO biomarker
|
KRAS (KRAS proto-oncogene GTPase) • CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • TNFA (Tumor Necrosis Factor-Alpha) • HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • CD4 (CD4 Molecule) • IL2 (Interleukin 2)
|
KRAS mutation • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G12A • KRAS G12 • KRAS G13
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • Hiltonol (poly-ICLC) • Undisclosed KRAS peptide vaccine